{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:00:22Z","timestamp":1792155622149,"version":"4.4.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":105,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.tcm.2025.01.007","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T12:08:12Z","timestamp":1739189292000},"page":"284-293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Atrial fibrillation burden and management in cardiomyopathies: Current evidence and unmet needs"],"prefix":"10.1016","volume":"35","author":[{"given":"Alexios S.","family":"Antonopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Kasiakogias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandrina","family":"Kouroutzoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Touloupaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Briasoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstathios","family":"Papatheodorou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelos G.","family":"Rigopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitra","family":"Antonakaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aggeliki","family":"Laina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Tsioufis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalambos","family":"Vlachopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Lazaros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tcm.2025.01.007_bib0001","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2025.01.007_bib0002","first-page":"22","article-title":"Atrial fibrillation in patients with inherited cardiomyopathies","volume":"21","author":"Yeung","year":"2019","journal-title":"Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol"},{"key":"10.1016\/j.tcm.2025.01.007_bib0003","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1093\/eurheartj\/ehx819","article-title":"The Cardiomyopathy Registry of the EURObservational Research Programme of the European Society of Cardiology: baseline data and contemporary management of adult patients with cardiomyopathies","volume":"39","author":"Charron","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2025.01.007_bib0004","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1002\/ehf2.12854","article-title":"Atrial fibrillation, anticoagulation management and risk of stroke in the Cardiomyopathy\/Myocarditis registry of the EURObservational Research Programme of the European Society of Cardiology","volume":"7","author":"Mizia-Stec","year":"2020","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.tcm.2025.01.007_bib0005","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1001\/jamacardio.2023.2808","article-title":"Cardiac remodeling in subclinical hypertrophic cardiomyopathy: the VANISH randomized clinical trial","volume":"8","author":"Vissing","year":"2023","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.tcm.2025.01.007_bib0006","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/jce.15304","article-title":"Impact of comorbidities on atrial fibrillation and sudden cardiac death in hypertrophic cardiomyopathy","volume":"33","author":"Sridharan","year":"2022","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.tcm.2025.01.007_bib0007","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/ejhf.2566","article-title":"Systemic embolism in amyloid transthyretin cardiomyopathy","volume":"24","author":"Vilches","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.tcm.2025.01.007_bib0008","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2025.01.007_bib0009","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021970","article-title":"Atrial fibrillation in patients with cardiomyopathy: prevalence and clinical outcomes from real-world data","volume":"10","author":"Buckley","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.tcm.2025.01.007_bib0010","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.hjc.2022.05.002","article-title":"Atrial fibrillation in hypertrophic cardiomyopathy \u2013 A contemporary mini-review","volume":"67","author":"Dragasis","year":"2022","journal-title":"Hellenic J Cardiol"},{"key":"10.1016\/j.tcm.2025.01.007_bib0011","first-page":"544","article-title":"Prognostic impact of atrial fibrillation in hypertrophic cardiomyopathy: a systematic review","volume":"110","author":"Alphonse","year":"2021","journal-title":"Clin Res Cardiol Off J Ger Card Soc"},{"key":"10.1016\/j.tcm.2025.01.007_bib0012","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2025.01.007_bib0013","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.amjcard.2016.08.092","article-title":"Incidence of device-detected atrial fibrillation and long-term outcomes in patients with hypertrophic cardiomyopathy","volume":"119","author":"van Velzen","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.tcm.2025.01.007_bib0014","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1161\/CIRCULATIONAHA.117.029267","article-title":"Clinical profile and consequences of atrial fibrillation in hypertrophic cardiomyopathy","volume":"136","author":"Rowin","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2025.01.007_bib0015","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000354953","article-title":"Clinical profile and prognostic significance of atrial fibrillation in hypertrophic cardiomyopathy","volume":"126","author":"Tian","year":"2013","journal-title":"Cardiology"},{"key":"10.1016\/j.tcm.2025.01.007_bib0016","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ijcard.2023.04.008","article-title":"Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring","volume":"381","author":"Fumagalli","year":"2023","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.tcm.2025.01.007_bib0017","doi-asserted-by":"crossref","unstructured":"2024 AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR Guideline for the management of Hypertrophic Cardiomyopathy: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines n.d. https:\/\/doi.org\/10.1161\/CIR.0000000000001250.","DOI":"10.1161\/CIR.0000000000001250"},{"key":"10.1016\/j.tcm.2025.01.007_bib0018","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1161\/STROKEAHA.115.012130","article-title":"Stroke and embolic events in hypertrophic cardiomyopathy: risk stratification in patients without atrial fibrillation","volume":"47","author":"Haruki","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.tcm.2025.01.007_bib0019","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0735-1097(01)01727-2","article-title":"Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy","volume":"39","author":"Maron","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2025.01.007_bib0020","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.120.009796","article-title":"Development and validation of a clinical predictive model for identifying hypertrophic cardiomyopathy patients at risk for atrial fibrillation: the HCM-AF score","volume":"14","author":"Carrick","year":"2021","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.tcm.2025.01.007_bib0021","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3121\/cmr.2010.908","article-title":"Impact of atrial fibrillation on outcome of patients with idiopathic dilated cardiomyopathy: data from the Heart Muscle Disease Registry of Trieste","volume":"8","author":"Aleksova","year":"2010","journal-title":"Clin Med Res"},{"key":"10.1016\/j.tcm.2025.01.007_bib0022","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1001\/jamacardio.2022.0810","article-title":"Mortality among patients with early-onset atrial fibrillation and rare variants in cardiomyopathy and arrhythmia genes","volume":"7","author":"Yoneda","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.tcm.2025.01.007_bib0023","unstructured":"Premature cardiac senescence in patients with lamin A\/C mutations: at least 5 years gap from electrical to mechanical dysfunction n.d. https:\/\/iris.unisr.it\/handle\/20.500.11768\/49900 (accessed January 21, 2024)."},{"key":"10.1016\/j.tcm.2025.01.007_bib0024","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.hjc.2023.04.008","article-title":"The burden of atrial fibrillation and heart failure in hospitalized patients: a real-world survey in a nationwide snapshot","volume":"74","author":"Iliodromitis","year":"2023","journal-title":"Hellenic J Cardiol"},{"key":"10.1016\/j.tcm.2025.01.007_bib0025","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/CIRCOUTCOMES.111.962688","article-title":"Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007","volume":"5","author":"Piccini","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.tcm.2025.01.007_bib0026","doi-asserted-by":"crossref","first-page":"37","DOI":"10.33963\/KP.15046","article-title":"The burden of atrial fibrillation and its prognostic value in patients with dilated cardiomyopathy","volume":"78","author":"Dziewi\u0119cka","year":"2020","journal-title":"Kardiol Pol"},{"key":"10.1016\/j.tcm.2025.01.007_bib0027","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jacep.2018.10.016","article-title":"Hypertrophic cardiomyopathy patients with paroxysmal atrial fibrillation have a high burden of left atrial fibrosis by Cardiac Magnetic resonance imaging","volume":"5","author":"Sivalokanathan","year":"2019","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.tcm.2025.01.007_bib0028","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.123.004301","article-title":"Imagenetics for precision medicine in dilated cardiomyopathy","volume":"17","author":"Antonopoulos","year":"2024","journal-title":"Circ Genomic Precis Med"},{"key":"10.1016\/j.tcm.2025.01.007_bib0029","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cardfail.2023.05.013","article-title":"Left atrial function in patients with Titin cardiomyopathy","volume":"30","author":"Henkens","year":"2024","journal-title":"J Card Fail"},{"key":"10.1016\/j.tcm.2025.01.007_bib0030","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1001\/jama.2018.18179","article-title":"Association between Titin loss-of-function variants and early-onset atrial fibrillation","volume":"320","author":"Choi","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.tcm.2025.01.007_bib0031","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/eurheartj\/ehx596","article-title":"Lamin A\/C cardiomyopathy: young onset, high penetrance, and frequent need for heart transplantation","volume":"39","author":"Hasselberg","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2025.01.007_bib0032","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jacc.2011.08.078","article-title":"Risk factors for malignant ventricular arrhythmias in lamin a\/c mutation carriers a European cohort study","volume":"59","author":"van Rijsingen","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2025.01.007_bib0033","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.jacc.2016.08.058","article-title":"Long-term arrhythmic and nonarrhythmic outcomes of lamin A\/C mutation carriers","volume":"68","author":"Kumar","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2025.01.007_bib0034","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/CIRCGENETICS.113.000374","article-title":"Outcome in phospholamban R14del carriers: results of a large multicentre cohort study","volume":"7","author":"van Rijsingen","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.tcm.2025.01.007_bib0035","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jacep.2017.12.003","article-title":"Filamin C truncation mutations are associated with arrhythmogenic dilated cardiomyopathy and changes in the cell-cell adhesion structures","volume":"4","author":"Begay","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.tcm.2025.01.007_bib0036","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/jce.13094","article-title":"Influence of genotype on structural atrial abnormalities and atrial fibrillation or flutter in arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"27","author":"Bourfiss","year":"2016","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.tcm.2025.01.007_bib0037","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.jacc.2016.09.927","article-title":"Truncating FLNC mutations are associated with high-risk dilated and arrhythmogenic cardiomyopathies","volume":"68","author":"Ortiz-Genga","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2025.01.007_bib0038","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/CIRCGEN.123.004059","article-title":"Risks of ventricular arrhythmia and heart failure in carriers of RBM20 variants","volume":"16","author":"Cannie","year":"2023","journal-title":"Circ Genomic Precis Med"},{"key":"10.1016\/j.tcm.2025.01.007_bib0039","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.jacc.2018.08.2181","article-title":"Dilated cardiomyopathy due to BLC2-associated athanogene 3 (BAG3) mutations","volume":"72","author":"Dom\u00ednguez","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2025.01.007_bib0040","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.hrthm.2013.08.032","article-title":"Prevalence of atrial arrhythmias in arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"10","author":"Camm","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.tcm.2025.01.007_bib0041","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.amjcard.2010.04.031","article-title":"Atrial arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy\/dysplasia and ventricular tachycardia","volume":"106","author":"Chu","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.tcm.2025.01.007_bib0042","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1111\/jce.14069","article-title":"Atrial arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy: prevalence, echocardiographic predictors, and treatment","volume":"30","author":"Cardona-Guarache","year":"2019","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.tcm.2025.01.007_bib0043","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.007344","article-title":"Atrial dysfunction in arrhythmogenic right ventricular cardiomyopathy","volume":"11","author":"Zghaib","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.tcm.2025.01.007_bib0044","doi-asserted-by":"crossref","first-page":"736","DOI":"10.5603\/CJ.a2018.0123","article-title":"Right atrial pathology in arrhythmogenic right ventricular dysplasia","volume":"26","author":"Li","year":"2019","journal-title":"Cardiol J"},{"key":"10.1016\/j.tcm.2025.01.007_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2023.101841","article-title":"Epicardial adipose tissue in myocardial disease: from physiology to heart failure phenotypes","volume":"48","author":"Antonopoulos","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.tcm.2025.01.007_bib0046","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jelectrocard.2010.08.008","article-title":"Abnormal atrial activation is common in patients with arrhythmogenic right ventricular cardiomyopathy","volume":"44","author":"Platonov","year":"2011","journal-title":"J Electrocardiol"},{"key":"10.1016\/j.tcm.2025.01.007_bib0047","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1016\/j.jacc.2016.09.951","article-title":"Arrhythmogenic right Ventricular cardiomyopathy: clinical course and predictors of arrhythmic risk","volume":"68","author":"Mazzanti","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2025.01.007_bib0048","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1161\/CIRCULATIONAHA.121.053521","article-title":"Phenotypic expression, natural history, and risk stratification of cardiomyopathy caused by filamin C truncating variants","volume":"144","author":"Gigli","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2025.01.007_bib0049","article-title":"Atrial tachyarrhythmias and heart failure events in patients with arrhythmogenic right ventricular cardiomyopathy","volume":"31","author":"Kikuchi","year":"2020","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1016\/j.tcm.2025.01.007_bib0050","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1016\/j.hrthm.2019.09.019","article-title":"2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy: executive summary","volume":"16","author":"Towbin","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.tcm.2025.01.007_bib0051","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.1093\/eurheartj\/ehac543","article-title":"Restrictive cardiomyopathy: definition and diagnosis","volume":"43","author":"Rapezzi","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2025.01.007_bib0052","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/ehjqcco\/qcaa075","article-title":"Prospective follow-up in various subtypes of cardiomyopathies: insights from the ESC EORP Cardiomyopathy Registry","volume":"7","author":"Gimeno","year":"2021","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.tcm.2025.01.007_bib0053","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.3390\/jcm12031236","article-title":"Prevalence and impact of arrhythmia on outcomes in restrictive cardiomyopathy\u2014A report from the Beijing Municipal Health Commission Information Center (BMHCIC) database","volume":"12","author":"Wang","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.tcm.2025.01.007_bib0054","first-page":"147","article-title":"Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role","volume":"22","author":"Longhi","year":"2015","journal-title":"Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis"},{"key":"10.1016\/j.tcm.2025.01.007_bib0055","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/ejhf.2776","article-title":"Prevalence, characteristics and outcomes of older patients with hereditary versus wild-type transthyretin amyloid cardiomyopathy","volume":"25","author":"Porcari","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.tcm.2025.01.007_bib0056","article-title":"Transthyretin amyloidosis cardiomyopathy in Greece: clinical insights from the National Referral Center","author":"Bampatsias","year":"2023","journal-title":"Hell J Cardiol HJC Hell Kardiologike Epitheorese"},{"key":"10.1016\/j.tcm.2025.01.007_bib0057","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.ehj.2004.04.007","article-title":"Amyloid deposition as a cause of atrial remodelling in persistent valvular atrial fibrillation","volume":"25","author":"Leone","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2025.01.007_bib0058","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.jacep.2019.10.013","article-title":"No association between CHADS-VASc score and left atrial appendage thrombus in patients with transthyretin amyloidosis","volume":"5","author":"Donnellan","year":"2019","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.tcm.2025.01.007_bib0059","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.016260","article-title":"Thinking outside the heart to treat atrial fibrillation in hypertrophic cardiomyopathy","volume":"9","author":"Rowin","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.tcm.2025.01.007_bib0060","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1093\/eurheartj\/ehx739","article-title":"Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial","volume":"39","author":"Rienstra","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2025.01.007_bib0061","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.jacc.2020.01.052","article-title":"Mobile health technology to improve care for patients with atrial fibrillation","volume":"75","author":"Guo","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2025.01.007_bib0062","unstructured":"2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines | circulation n.d. https:\/\/www.ahajournals.org\/doi\/10.1161\/CIR.0000000000001193 (accessed December 3, 2024)."},{"key":"10.1016\/j.tcm.2025.01.007_bib0063","unstructured":"2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) | European Heart Journal | Oxford Academic n.d. https:\/\/academic.oup.com\/eurheartj\/article\/45\/36\/3314\/7738779 (accessed December 3, 2024)."},{"key":"10.1016\/j.tcm.2025.01.007_bib0064","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA Guideline for the management of Heart Failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2025.01.007_bib0065","first-page":"euad101","article-title":"Surgical and transcatheter left atrial appendage closure in patients with atrial fibrillation and hypertrophic cardiomyopathy","volume":"25","author":"Khawaja","year":"2023","journal-title":"Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol"},{"key":"10.1016\/j.tcm.2025.01.007_bib0066","article-title":"Combining catheter ablation and left atrial appendage occlusion in high-risk patients with atrial fibrillation: a propensity score-matched analysis","author":"Hao","year":"2024","journal-title":"Hellenic J Cardiol"},{"key":"10.1016\/j.tcm.2025.01.007_bib0067","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.amjcard.2019.12.025","article-title":"Strict versus lenient versus poor rate control among patients with atrial fibrillation and heart failure (from the Get With The Guidelines - Heart Failure Program)","volume":"125","author":"Hess","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.tcm.2025.01.007_bib0068","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1016\/j.jacc.2017.04.001","article-title":"Heart rate and rhythm and the benefit of beta-blockers in patients with Heart failure","volume":"69","author":"Kotecha","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2025.01.007_bib0069","first-page":"409","article-title":"Atrial fibrillation in hypertrophic cardiomyopathy: pathophysiology, diagnosis and management","volume":"10","author":"Falasconi","year":"2020","journal-title":"Am J Cardiovasc Dis"},{"key":"10.1016\/j.tcm.2025.01.007_bib0070","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/14656566.2019.1702023","article-title":"Pharmacotherapy for the treatment of obstructive hypertrophic cardiomyopathy","volume":"21","author":"Spoladore","year":"2020","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.tcm.2025.01.007_bib0071","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s43856-023-00315-8","article-title":"Efficacy and safety of dofetilide and sotalol in patients with hypertrophic cardiomyopathy","volume":"3","author":"Chen","year":"2023","journal-title":"Commun Med"},{"key":"10.1016\/j.tcm.2025.01.007_bib0072","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.hjc.2022.11.002","article-title":"Current and emerging perspectives on pathophysiology, diagnosis, and management of hypertrophic cardiomyopathy","volume":"70","author":"Gartzonikas","year":"2023","journal-title":"Hellenic J Cardiol"},{"key":"10.1016\/j.tcm.2025.01.007_bib0073","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jacep.2020.11.021","article-title":"Atrial fibrillation burden and clinical outcomes in heart failure: the CASTLE-AF trial","volume":"7","author":"Brachmann","year":"2021","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.tcm.2025.01.007_bib0074","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.jacc.2017.10.054","volume":"72","author":"Al-Khatib","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2025.01.007_bib0075","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.008168","article-title":"Clinical outcomes and characteristics with dofetilide in atrial fibrillation patients considered for implantable cardioverter-defibrillator","volume":"13","author":"Koene","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.tcm.2025.01.007_bib0076","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.hroo.2023.01.002","article-title":"Catheter ablation of atrial fibrillation in hypertrophic cardiomyopathy: a proportional meta-analysis and systematic review of single-arm studies","volume":"4","author":"Latif","year":"2023","journal-title":"Heart Rhythm O2"},{"key":"10.1016\/j.tcm.2025.01.007_bib0077","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.720950","article-title":"Clinical efficacy and safety of Cox-Maze IV procedure for atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy","volume":"8","author":"Meng","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.tcm.2025.01.007_bib0078","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2025.01.007_bib0079","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jacep.2019.03.009","article-title":"Atrial remodeling following catheter ablation for Atrial fibrillation-mediated cardiomyopathy: long-term follow-up of CAMERA-MRI study","volume":"5","author":"Sugumar","year":"2019","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.tcm.2025.01.007_bib0080","doi-asserted-by":"crossref","first-page":"4962","DOI":"10.3390\/jcm10214962","article-title":"Efficacy of catheter ablation for atrial arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy-A multicenter study","volume":"10","author":"Gasperetti","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.tcm.2025.01.007_bib0081","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/ejhf.316","article-title":"Prediction of thrombo-embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk-CVA)","volume":"17","author":"Guttmann","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.tcm.2025.01.007_bib0082","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.amjcard.2020.09.006","article-title":"Predictors and mechanisms of atrial fibrillation in patients with hypertrophic cardiomyopathy","volume":"136","author":"Raphael","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.tcm.2025.01.007_bib0083","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1161\/hc4601.097997","article-title":"Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy","volume":"104","author":"Olivotto","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2025.01.007_bib0084","first-page":"577","article-title":"Sarcomeric hypertrophic cardiomyopathy: genetic profile in a Portuguese population","volume":"31","author":"Brito","year":"2012","journal-title":"Rev Port Cardiol Orgao Of Soc Port Cardiol Port J Cardiol Off J Port Soc Cardiol"},{"key":"10.1016\/j.tcm.2025.01.007_bib0085","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1089\/109065703321560895","article-title":"Utility of genetic screening in hypertrophic cardiomyopathy: prevalence and significance of novel and double (homozygous and heterozygous) beta-myosin mutations","volume":"7","author":"Mohiddin","year":"2003","journal-title":"Genet Test"},{"key":"10.1016\/j.tcm.2025.01.007_bib0086","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.3390\/jcm12134484","article-title":"Clinical application of the HCM-AF risk score in the prediction of Clinical outcomes of Polish patients with hypertrophic cardiomyopathy","volume":"12","author":"Stec","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.tcm.2025.01.007_bib0087","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/jce.12982","article-title":"High incidence of de novo and subclinical atrial fibrillation in patients with hypertrophic cardiomyopathy and Cardiac rhythm management device","volume":"27","author":"Wilke","year":"2016","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.tcm.2025.01.007_bib0088","first-page":"1182","article-title":"Supraventricular arrhythmias in patients with arrhythmogenic right ventricular dysplasia\/cardiomyopathy associate with long-term outcome after catheter ablation of ventricular tachycardias","volume":"20","author":"M\u00fcssigbrodt","year":"2018","journal-title":"Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol"},{"key":"10.1016\/j.tcm.2025.01.007_bib0089","first-page":"596","article-title":"Thromboembolic complications in patients with arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"8","author":"Wlodarska","year":"2006","journal-title":"Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol"},{"key":"10.1016\/j.tcm.2025.01.007_bib0090","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.amjcard.2016.06.003","article-title":"Atrial remodeling and Atrial tachyarrhythmias in arrhythmogenic right ventricular cardiomyopathy","volume":"118","author":"Wu","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.tcm.2025.01.007_bib0091","doi-asserted-by":"crossref","DOI":"10.1186\/s12881-020-0955-z","article-title":"DSP p.(Thr2104Glnfs*12) variant presents variably with early onset severe arrhythmias and left ventricular cardiomyopathy","volume":"21","author":"Heli\u00f6","year":"2020","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.tcm.2025.01.007_bib0092","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1001\/jama.293.4.447","article-title":"Sodium channel mutations and susceptibility to heart failure and atrial fibrillation","volume":"293","author":"Olson","year":"2005","journal-title":"JAMA"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173825000222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173825000222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T18:52:56Z","timestamp":1760640776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173825000222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":92,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1050173825000222"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2025.01.007","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atrial fibrillation burden and management in cardiomyopathies: Current evidence and unmet needs","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2025.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}